CN Stock MarketDetailed Quotes

000627 Hubei Biocause Pharmaceutical

Watchlist
  • 3.41
  • +0.31+10.00%
Market Closed Sep 13 15:00 CST
16.85BMarket Cap-20297P/E (TTM)

Hubei Biocause Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hubei Biocause Pharmaceutical Q2 2024 Earnings Date

Currency：CNYAug 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
11.57B
--
+0.58%
Net Income
--
-538.95M
--
-17.44%
Analyst Rating
No Data

Hubei Biocause Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

No Data

Hubei Biocause Pharmaceutical Earnings Reports

  • Tianmao Group: Guohua Life 2024 Semi-Annual Report

    Aug 30 12:00 ET

  • Tianmao Group: 2024 Semi-Annual Report

    Aug 30 12:00 ET

  • Tianmao Group: 2024 Semi-Annual Report Summary

    Aug 30 12:00 ET

  • Hubei Biocause Pharmaceutical: 2024-043- Hubei Biocause Pharmaceutical's half-year performance forecast for 2024.

    Jul 8 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data